Vimarsana
Biggest News Aggregation in the World

Page 23 - Collaborating Centre News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Collaborating Centre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Collaborating Centre Today - Breaking & Trending Today

$9.6M boost for international mother-baby iron supplements study - Vimarsana News

$9.6M boost for international mother-baby iron supplements study

 E-Mail Credit: WEHI, Australia A Melbourne-led research consortium investigating the impact of iron treatments on maternal and newborn health in low-income countries has received two major grants from the Bill & Melinda Gates Foundation worth almost $US 9.6 million. The funding, awarded in 2020, will support major clinical trials in Malawi, South Asia, Africa and Bangladesh, investigating whether intravenous iron treatment given to women in pregnancy improves the physical and psychological health of mothers, and the growth and brain development of their babies. The study will also address w...

F. Hoffmann-La Roche Ltd: Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020 - Vimarsana News

F. Hoffmann-La Roche Ltd: Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020

F. Hoffmann-La Roche Ltd: Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020 25.8 DFS, HR (95% CI) (0.19-0.60) About bladder cancer and muscle-invasive urothelial cancer In 2018, there were over half a million new cases of bladder cancer diagnosed globally, with approximately 200,000 deaths from the disease. 4 Urothelial cancer is the most common type of bladder cancer, accounting for about 90-95% of all cases. 5 MIUC is a type of urothelial cancer that has spread into the muscle of the bladder, ureter...

Investegate |F. Hoffmann-La Roche Ltd Announcements | F. Hoffmann-La Roche Ltd: Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020 - Vimarsana News

Investegate |F. Hoffmann-La Roche Ltd Announcements | F. Hoffmann-La Roche Ltd: Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020

F. Hoffmann-La Roche Ltd Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020 Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020 People with muscle-invasive urothelial cancer (MIUC) who had detectable circulating tumour DNA (ctDNA) were more likely to benefit from treatment with adjuvant (after surgery) Tecentriq monotherapy, compared with those without ctDNA The goal of current treatment in people with MIUC is to ...

FactCheck: Have manufacturers provided 'incomplete testing data' meaning their vaccines won't be approved? - Vimarsana News

FactCheck: Have manufacturers provided 'incomplete testing data' meaning their vaccines won't be approved?

FactCheck: Have manufacturers provided 'incomplete testing data' meaning their vaccines won't be approved? False claims have spread on social media about Covid-19 testing and vaccination. By Lauren Boland Thursday 10 Dec 2020, 9:00 PM Dec 10th 2020, 9:00 PM 16,512 Views 0 Comments A CLAIM SHARED ON social media in Ireland has suggested that regulators will not sign off on a Covid-19 vaccine due to “incomplete testing data”. The claim app...